NSI-189 Freebase

NSI-189 Freebase brings a distinctive idea to the world of nootropics: exploring the brain’s ability to build and maintain the connections behind memory and learning. Its appeal centres on brain adaptability, memory and nerve-cell resilience—themes that have attracted attention in laboratory studies and a substantial clinical research programme.

Supplied here as a freebase powder, NSI-189 is a small molecule, not a peptide. The studies discussed below principally used the phosphate form; they explain the interest in NSI-189, but do not establish equivalent effects for this freebase powder.

i) The Pharmacology of NSI-189

1. Building the connections behind learning

Learning depends on nerve cells making connections and strengthening the ones we use. The hippocampus, a brain region important for forming memories, is a particular focus of NSI-189 research.

In laboratory brain tissue, NSI-189 phosphate strengthened a process that helps nerve cells hold on to a signal after repeated activity. Think of it as making a frequently used connection easier to activate again. Animal studies also found improvements in selected learning and memory tasks. These findings underpin its potential for supporting the processes behind learning and recall.

2. Helping nerve cells withstand difficult conditions

Nerve cells need both a steady energy supply and healthy connections to keep communicating. In diabetic rats, NSI-189 phosphate improved memory performance alongside changes in the cells’ energy-producing machinery and proteins involved in nerve-cell connections.

A separate stroke study in rats found better movement and neurological performance, while related cell experiments showed growth of nerve-cell branches. Together, these findings give NSI-189 an interesting nerve-cell resilience profile: the possibility of helping damaged or stressed networks maintain more of their function.

3. The link between cognition and mood

NSI-189 has also been studied for the overlap between cognitive difficulties and depression. Early trials and selected secondary measures suggested improvements worth investigating. However, the larger 220-person phosphate trial and the later 301-person ALTO-100 trial did not meet their main depression outcomes. Human brain regrowth and reliable mood or memory benefits have therefore not been established.

Summary of Pharmacological Activity

ii) Potential / Hypothetical Profile

• Learning & Recall: The possibility of strengthening the connections that help new information become lasting memories is central to NSI-189’s appeal.
• Brain Adaptability: Interest in how nerve-cell networks can form and adjust connections—the biological groundwork for learning something new.
• Nerve-Cell Resilience: A potential role in maintaining cellular energy and communication under challenging conditions, based on the preclinical findings above.

Selected References

• Synaptic plasticity and learning: laboratory and mouse study
• Cellular energy and memory in diabetic rats
• Nerve-cell growth and functional outcomes in stroke models
• Phase 2 clinical study of NSI-189 phosphate
• ALTO-100: Phase 2b trial results